The results showed a trend toward mildly reduced frequency of white blood cells counts in mice treated with both single modality of apatinib (200 mg/kg) and combined strategy with SABR, without showing any other myelosuppressive toxicity ( Fig. 2B ). 2.
← all excerpts
Apatinib Combined with Local Irradiation Leads to Systemic Tumor Control via Reversal of Immunosuppressive Tumor Microenvironment in Lung Cancer.
1
—
—